Continuous Glucose Monitoring in Infants

NCT04458649 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2024-07-03

No results posted yet for this study

Summary

The purpose of this study is to employ continuous glucose monitoring to measure glucose profiles in newborn infants.

Conditions

  • Neonatal Hypoglycemia

Interventions

DEVICE

Dexcom continuous glucose monitor

Measurement of interstitial glucose

Sponsors & Collaborators

Principal Investigators

  • Jane Kim, MD · University of California San Diego/Rady Children's Hospital

Eligibility

Min Age
1 Hour
Max Age
2 Hours
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2024-12-31
Completion
2024-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04458649 on ClinicalTrials.gov